| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 05/06/2009 | EP2054420A1 Benzimidazoý1,2-c¨ý1,2,3¨thiadiazol-7-sulfonamides as inhibitors of carbonic anhydrase and the intermediates for production thereof |
| 05/06/2009 | EP2054409A2 Therapeutic substituted thiazolidinones, oxazolidinones, and related compounds |
| 05/06/2009 | EP2054389A1 6-substituted isoquinoline derivatives as rock-1 inhibitors |
| 05/06/2009 | EP1414525B1 2-(3,5-bis-trifluoromethyl-phenyl)-n-¬6-(1,1-dioxo-1.lambda.6-thiomorpholin-4-yl)-4-(2-methyl or 4-fluoro-2-methyl substituted)phenyl-pyridin-3-yl -n-methyl-isobutyramide |
| 05/06/2009 | EP1308440B1 Piperidine derivatives and drugs containing these derivatives as the active ingredient |
| 05/06/2009 | CN101426792A Pyrazolopyrimidines as therapeutic agents |
| 05/06/2009 | CN101426534A Methods and compositions for detecting and treating retinal diseases |
| 05/06/2009 | CN101426487A Formulations containing amide derivatives of carboxylic acidnsaids for topical administration to the eye |
| 05/06/2009 | CN101422595A Traditional Chinese medicine composition for treating dizziness and preparation method and quality control method thereof |
| 05/06/2009 | CN101422510A Traditional Chinese medicine decoction for treating wind-heat type common cold |
| 05/06/2009 | CN100484957C Thymosin beta4 derivative and its use |
| 05/06/2009 | CN100484939C Polymorph forms of N-(2,3-dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4-yl)-2-(2-oxopyrrolidin-1-yl) acetamide |
| 05/06/2009 | CN100484933C Novel pyrazine compounds, their use in preparing medicament for treating diseases correlated with serotonin |
| 05/06/2009 | CN100484528C Pharmaceutical composition containing prostaglandin |
| 05/06/2009 | CN100484417C Health care bamboo salt and its preparing method |
| 05/05/2009 | US7528231 Kv10.1, a novel voltage-gated potassium channel from human brain |
| 05/05/2009 | US7528162 such as 3-(4-Chlorophenyl)-N'-((4-chlorophenyl)sulfonyl)-N-(piperidin-1-yl)-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboxamidine, used as cannabinoid (CB1) receptor antagonists, for prophylaxis of psychological disorders |
| 05/05/2009 | US7528113 Method and composition for the treatment of adenoviral ocular infections |
| 05/05/2009 | US7528110 Anti-allergic complex molecules |
| 05/05/2009 | CA2347863C Treatment of disorders of the outer retina |
| 04/30/2009 | WO2009055289A2 Therapeutic substituted lactams |
| 04/30/2009 | WO2009019555A3 Ophthalmic formulation containing paracetamol |
| 04/30/2009 | WO2008094989A3 Punctal plugs and methods of delivering therapeutic agents |
| 04/30/2009 | WO2008046598A8 DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL)PHENOL AS AGONISTS OF THE β2 ADRENERGIC RECEPTOR |
| 04/30/2009 | WO2007014327A3 Small compounds that correct protein misfolding and uses thereof |
| 04/30/2009 | US20090111890 to stimulate hair growth, restore hair color to depigmented hair, alopecia; side effects reduction; (16-(3-chlorophenoxy)-17, 18, 19, 20-tetranor PGF2 alpha ) cyclopropyl methyl amide |
| 04/30/2009 | US20090111889 Prostaglandin Analog Compositions To Treat Epithelial-Related Conditions |
| 04/30/2009 | US20090111883 Prostaglandin Analog Compositions To Treat Epithelial-Related Conditions |
| 04/30/2009 | US20090111882 Prostaglandin analog compositions and methods to treat epithelial-related conditions |
| 04/30/2009 | US20090111881 Prostaglandin Analog Compositions To Treat Epithelial-Related Conditions |
| 04/30/2009 | US20090111880 Prostaglandin Analog Compositions And Methods To Treat Epithelial-Related Conditions |
| 04/30/2009 | US20090111778 2-Keto-Oxazoles as Modulators of Fatty Acid Amide Hydrolase |
| 04/30/2009 | US20090111770 Pharmaceutical Composition Free From Dexpanthenol, Calcium Ions, and Phosphate and Use of Calcium Chelating Agent and Ophthalmologically Compatible Viscosity Regulator |
| 04/30/2009 | US20090111765 Compositions and methods for immunostimulatory rna oligonucleotides |
| 04/30/2009 | US20090110734 Quaternised ammonium cyclodextrin compounds |
| 04/30/2009 | CA2703479A1 Therapeutic substituted lactams |
| 04/30/2009 | CA2702984A1 Compositions and methods for treatment of diabetic retinopathy |
| 04/29/2009 | EP2053135A1 Bone morphonic proteins (BMP), BMP receptors and BMP binding proteins and their use in the diagnosis and treatment of glaucoma |
| 04/29/2009 | EP2053038A1 Aminoalcohol derivative and immunosuppressant containing the same as an active ingredient |
| 04/29/2009 | EP2052720A2 Use of at least one hydroxylamine compound for the treatment of eye disease |
| 04/29/2009 | EP2051712A2 Modulators of muscarinic receptors |
| 04/29/2009 | EP1904056B1 Use of a macrolide to restore corneal sensation |
| 04/29/2009 | EP1345910B1 Quinazoline derivatives, medicaments containing said compounds, their utilization and method for the production thereof |
| 04/29/2009 | EP1218509B1 Fibroblast growth factor-like polypeptides |
| 04/29/2009 | CN101417971A Indolines compounds, preparation method and pharmaceutical application thereof |
| 04/29/2009 | CN101417088A Chinese patent medicine for treating diabetic cataract |
| 04/29/2009 | CN101416940A Eye sterile suspension containing loteprednol etabonate and preparation method thereof |
| 04/29/2009 | CN100482684C Cytokine protein family |
| 04/29/2009 | CN100482664C 1,5-disubstituted-3,4-dihydro-1H-pyrimido [4,5-D] pyrimidi-2-one compounds and their use in treating CSBP/P38 kinase mediated diseases |
| 04/29/2009 | CN100482262C Herbal pharmaceutical compositions for treating immun logical disorders |
| 04/29/2009 | CN100482233C Compositions and methods for treating amyloidosis |
| 04/29/2009 | CN100482216C Use of hydroxide-releasing agents as skin permeation enhancers |
| 04/28/2009 | US7524874 Vanilloid receptor ligands and their use in treatments |
| 04/28/2009 | US7524852 Bicyclic pyrimidine derivatives |
| 04/28/2009 | US7524841 4,4-disubstituted piperidine derivatives having CCR3 antagonism |
| 04/28/2009 | US7524834 Antiinflammatory and antiallergic glucocorticosteroid, sterile glucocorticosteroids |
| 04/28/2009 | US7524675 Administering a polynucleotide encoding a Mycrobacterium kansasii-derived alpha antigen; asthma, atopic dermatitis, allergic rhinitis, allergic conjunctivitis |
| 04/28/2009 | US7524649 Chimeric polypeptide having a modified binding domain of growth hormone linked to a receptor binding domain of growth hormone receptor; treating giantism; acromegaly; cancer diabetic retinopathy; diabetic nephropathy, diabetic complications and any disease of growth hormone excess |
| 04/28/2009 | US7524512 Applying L-ascorbic acid in highly acidic concentration to middle ear |
| 04/28/2009 | CA2222964C Oxygen activatable formulations for disinfection or sterilization |
| 04/23/2009 | WO2009052140A1 Use of tnf receptor antagonists for treating dry eye |
| 04/23/2009 | WO2009051992A1 Compositions and methods for treating diseases involving ocular angiogenesis by inhibiting one or more selected receptor tyrosine kinases |
| 04/23/2009 | WO2009051670A2 Oxylipin compounds for the treatment of ophthalmic conditions |
| 04/23/2009 | WO2009051666A1 Therapeutic applications of fatty acid amide hydrolase inhibitors |
| 04/23/2009 | WO2009051244A1 Heterocyclic compound |
| 04/23/2009 | WO2009051223A1 Pharmaceutical composition for treatment of cataract |
| 04/23/2009 | WO2009050575A1 Inhibitors of fungal biofilm-formation |
| 04/23/2009 | WO2009050348A1 Tricyclic n-heteroaryl-carboxamide derivatives, preparation thereof and therapeutic use of same |
| 04/23/2009 | WO2009030890A9 Pyrimidine compounds for the treatment of cancer, septic shock and/or primary open angle glaucoma |
| 04/23/2009 | WO2009029762A3 Farnesylamine inhibitors of the visual cycle |
| 04/23/2009 | WO2009013915A8 Inhibitor of plasminogen activator inhibitor-1 |
| 04/23/2009 | WO2008101195A3 Drug resistance reversal in neoplastic disease |
| 04/23/2009 | US20090105478 Novel compounds |
| 04/23/2009 | US20090105342 Pufa supplements |
| 04/23/2009 | US20090105313 Preventive or therapeutic agent for keratoconjunctival disorder |
| 04/23/2009 | US20090105234 EP4 Receptor Agonist, Compositions and Methods Thereof |
| 04/23/2009 | US20090105176 Methods and Compositions for the Treatment of Eye Disorders with Increased Intraocular Pressure |
| 04/23/2009 | US20090105175 Methods and Compositions for the Treatment of Eye Disorders with Increased Intraocular Pressure |
| 04/23/2009 | US20090105163 Conjugates of Immune Cell Specific Macrolide Compounds with Anti-Inflammatory Compounds for Improved Cellular Targeting of Anti-Inflammatory Therapy |
| 04/23/2009 | US20090104694 Isolation and transplantation of retinal stem cells |
| 04/23/2009 | US20090104243 Drug cores for sustained release of therapeutic agents |
| 04/23/2009 | US20090104194 Bi-directional antibody for treatment of ocular disorders |
| 04/23/2009 | CA2702885A1 Pharmaceutical composition for treatment of cataract |
| 04/23/2009 | CA2702475A1 Compositions and methods for the treatment of ophthalmic conditions |
| 04/23/2009 | CA2702468A1 Therapeutic applications of fatty acid amide hydrolase inhibitors |
| 04/23/2009 | CA2694994A1 Tricyclic n-heteroaryl-carboxamide derivatives, preparation thereof and therapeutic use of same |
| 04/22/2009 | EP2050751A1 Compounds specific to adenosine A1 and A3 receptors and uses thereof |
| 04/22/2009 | EP2050750A2 Multicyclic compounds and their use as inhibitors of PARP, VEGFR2 and MLK3 enzymes |
| 04/22/2009 | EP2050744A1 Quinazoline derivatives as angiogenesis inhibitors |
| 04/22/2009 | EP2050450A1 1-Piperidine-2-cyanoimino-1,3-dihydro-2H-benzimidazole derivatives as nociceptin analogs with ORL1 modulating activity for the treatment of pain |
| 04/22/2009 | EP2050449A1 Aqueous liquid preparation containing amide compound |
| 04/22/2009 | EP2049495A2 N-aryl or n-heteroaryl pyrazolidine and pyrazolidinone derivatives as prostaglandine receptor inhibitors |
| 04/22/2009 | EP2049122A1 Methods and compositions for inhibiting angiogenesis |
| 04/22/2009 | EP2049112A2 Treating infections and sequelae thereof with combined dissociated glucocorticoid receptor agonists and anti-infective agents |
| 04/22/2009 | EP1551865B1 Hybrid molecules of macrolides with steroidal/non-steroidal anti-inflammatory molecules |
| 04/22/2009 | EP1507529B1 Combination comprising valsartan, amlodipine and hydrochlorothiazide |
| 04/22/2009 | CN101415407A Use of inhibitors of JUN N-terminal kinases to treat glaucoma |
| 04/22/2009 | CN101411876A Neurotoxic oligomers |
| 04/22/2009 | CN101411823A Medicinal granules for preventing optic atrophy of old age |
| 04/22/2009 | CN101411809A Medicament for blocked tear gland induced infection contamination |